ZimVie Q1 net sales $118.2M, net loss ($11.5M); completed spine sale for $375M, repaid $275M debt

ZimVie Inc.

2024-Q1 EPS reported -$0.29 revenue$118,195,000

Q1 net sales from continuing ops $118.2M, down 1.6% YoY; net loss ($11.5M) improved from ($16.4M) YoY.
Adjusted EBITDA $12.5M (10.5% margin) vs $10.7M (8.8% margin) in Q1 2023; adjusted EPS $0.08.
On April 1, 2024, closed sale of spine business for $375M and repaid $275M of debt.
FY 2024 guidance: net sales $450M-$460M, adjusted EBITDA $60M-$65M, adjusted EPS $0.55-$0.70.
Company refocused as pure-play dental; weighted average shares 27.1M.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ZimVie Inc. reported the quarter ended March 31, 2024 results: revenue $118.2 million, net income ($11.5) million, EPS ($0.42). Guidance reaffirmed.

Period: the quarter ended March 31, 2024
Revenue: $118.2 million
Net income: ($11.5) million
EPS: ($0.42)
Guidance: reaffirmed
Result: reported results

Exact text from the filing

part of this report. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 ZimVie Reports First Quarter 2024 Financial Results • Third Party Net Sales from Continuing Operations of $118.2 million • Net Loss from Continuing Operations of ($11.5) million; Net Loss margin of (9.7%) • Adjusted EBITDA [1] from Continuing Operations of $12.5 million; Adjusted EBITDA [1] margin

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001193125-24-134207

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.